Patents by Inventor Peter J. Krause

Peter J. Krause has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR THE TREATMENT AND PREVENTION OF NON-VIRAL TICK-BORNE DISEASES AND SYMPTOMS THEREOF OF
    Publication number: 20240408074
    Abstract: Methods and compositions for treating or preventing non-viral tick-borne diseases and symptoms thereof by administering a long half-life 8-aminoquinoline, such as tafenoquine, are disclosed. Kits including a means for testing for a non-viral tick-borne disease and/or symptoms thereof and a long half-life 8-aminoquinoline, such as tafenoquine, are disclosed.
    Type: Application
    Filed: April 19, 2024
    Publication date: December 12, 2024
    Applicants: 60 DEGREES PHARMACEUTICALS LLC, Tufts Medical Center, Inc., Yale Universtiy
    Inventors: Geoffrey S. Dow, Bryan L. Smith, Edouard Vannier, Peter J. Krause
  • Enhanced chemiluminescent enzyme-linked immunosorbent assay for detection of antibodies against
    Patent number: 11639930
    Abstract: Identification of immunodominant Babesia microti antigens using genome-wide immunoscreening is described. Candidate antigens were screened against sera from patients with clinical babesiosis. Also described are diagnostic assays with high sensitivity and specificity for detecting B. microti-specific antibodies in patient samples using the identified immunodominant antigens.
    Type: Grant
    Filed: November 1, 2018
    Date of Patent: May 2, 2023
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, Yale University
    Inventors: Sanjai Kumar, Nitin Verma, Ankit Puri, Peter J. Krause
  • ENHANCED CHEMILUMINESCENT ENZYME-LINKED IMMUNOSORBENT ASSAY FOR DETECTION OF ANTIBODIES AGAINST BABESIA MICROTI
    Publication number: 20210181190
    Abstract: Identification of immunodominant Babesia microti antigens using genome-wide immunoscreening is described. Candidate antigens were screened against sera from patients with clinical babesiosis. Also described are diagnostic assays with high sensitivity and specificity for detecting B. microti-specific antibodies in patient samples using the identified immunodominant antigens.
    Type: Application
    Filed: November 1, 2018
    Publication date: June 17, 2021
    Applicants: The U.S.A., as represented by the Secretary, Department of Health and Human Services, Yale University
    Inventors: Sanjai Kumar, Nitin Verma, Ankit Puri, Peter J. Krause